First-in-human Phase 1A Study of RGT-419B, a Next Generation CDK4 Inhibitor, in Patients (pts) with Hormone Receptor Positive (HR+) HER2advanced/metastatic Breast Cancer (ABC) Who Progressed on Prior CDK4/6 Inhibitors (Cdk4/6i)
CANCER RESEARCH(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要